Geley L
Wien Klin Wochenschr. 1978 Jul 14;90(14):506-9.
Acerbine has been available for clinical trial since three years ago. Promotion of epithelialization, as well as antiphlogistic, antibacterial and fungicidal actions have been attributed to this preparation. This paper presents a critical appraisal of our own results with Acerbine; initial scepsis was soon dispelled by the evident efficacy of this preparation, both in the form of a lotion and ointment, and its wide scope of application. Moreover, our own studies revealed an excellent effect on keloids, which became smoother and visibly paler. A very good prophylactic and curative effect was observed in respect to all types of skin transplantation. So far Acerbine has been successfully applied in 117 patients who have completed their course of treatment. Acerbine is being currently employed in the case of 16 further patients who are still in hospital. No untoward side effects were recorded. Our findings confirm the opinion of other authors that hospitalization is shortened by the use of this preparation. The availability, more recently, of the new preparation in form of an ointment enables treatment to be continued on an ambulant basis or at home in many cases. Certain new fiies. The results of further explorative investigations into these aspects are under review at present.
三年来,Acerbine一直可用于临床试验。该制剂具有促进上皮化以及抗炎、抗菌和杀菌作用。本文对我们使用Acerbine的结果进行了批判性评估;这种制剂无论是洗剂还是软膏形式,其明显的疗效和广泛的应用范围很快消除了最初的疑虑。此外,我们自己的研究表明,它对瘢痕疙瘩有极佳效果,瘢痕疙瘩变得更平滑且明显变淡。在所有类型的皮肤移植方面都观察到了非常好的预防和治疗效果。到目前为止,Acerbine已成功应用于117名完成治疗疗程的患者。目前,另外16名仍住院的患者正在使用Acerbine。未记录到不良副作用。我们的研究结果证实了其他作者的观点,即使用这种制剂可缩短住院时间。最近,新的软膏制剂可供使用,这使得在许多情况下可以在门诊或家中继续治疗。某些新问题。目前正在审查对这些方面进一步探索性研究的结果。